Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli

10 May 2021

Abstract excerpt

The increasing prevalence of antimicrobial resistance has become a global health problem. Acinetobacter baumannii is an important nosocomial pathogen due to its capacity to persist in the hospital environment. It has a high mortality rate and few treatment options. Antibiotic combinations can help to fight multi-drug resistant (MDR) bacterial infections, but they are rarely used in the clinics and mostly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33972678
DOI: 10.1038/s42003-021-02074-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coliPMID 33972678Read ↗

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.Semantic proximity Read ↗

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsSemantic proximity Read ↗

Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolatesSemantic proximity Read ↗

In vitro Synergistic Activity of Antimicrobial Combinations Against blaKPC and blaNDM-Producing Enterobacterales With blaIMP or mcr GenesSemantic proximity Read ↗

Synergistic combination of two antimicrobial agents closing each other's mutant selection windows to prevent antimicrobial resistance.Semantic proximity Read ↗

Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced Acinetobacter baumanniiSemantic proximity Read ↗

Combating Multidrug Resistance in Escherichia coli and Klebsiella pneumoniae: A Synergistic Approach with Repurposed DrugsSemantic proximity Read ↗

Comprehensive In Vitro Evaluation of Antimicrobial Combinations Against Extensively Drug- Resistant Acinetobacter baumannii: Planktonic and Biofilm PerspectivesSemantic proximity Read ↗

Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates.Semantic proximity Read ↗

In vitro synergistic potentials of novel antibacterial combination therapies against Salmonella enterica serovar TyphimuriumSemantic proximity Read ↗

Temperate phage-antibiotic synergy is widespread, but varies by phage, host, and antibiotic pairingSemantic proximity Read ↗

Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.